Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.32B | 1.33B | 1.22B | 1.10B | 903.70M | 958.10M |
Gross Profit | 843.40M | 917.40M | 815.20M | 733.60M | 554.00M | 593.30M |
EBITDA | 274.20M | 244.30M | 236.50M | 263.70M | 192.10M | 255.20M |
Net Income | 72.70M | 58.40M | 72.70M | 94.60M | 70.30M | 148.00M |
Balance Sheet | ||||||
Total Assets | 1.72B | 1.48B | 1.59B | 1.34B | 1.51B | 1.11B |
Cash, Cash Equivalents and Short-Term Investments | 285.20M | 144.90M | 286.50M | 287.70M | 477.90M | 31.70M |
Total Debt | 831.10M | 728.40M | 754.00M | 620.70M | 622.60M | 386.00M |
Total Liabilities | 1.21B | 1.06B | 1.11B | 912.70M | 907.10M | 592.50M |
Stockholders Equity | 494.70M | 417.00M | 469.50M | 427.90M | 600.10M | 520.20M |
Cash Flow | ||||||
Free Cash Flow | 213.00M | 108.10M | 68.20M | 114.40M | 261.70M | 200.00K |
Operating Cash Flow | 237.50M | 164.60M | 116.30M | 151.60M | 293.70M | 62.50M |
Investing Cash Flow | -28.10M | -72.40M | -45.30M | -37.20M | -32.00M | -62.30M |
Financing Cash Flow | -85.10M | -232.80M | -80.70M | -298.20M | 197.00M | -58.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
67 Neutral | C$1.52B | 15.99 | 19.34% | ― | 4.64% | 41.68% | |
66 Neutral | £1.85B | 11.46 | 6.20% | 2.99% | 0.64% | -17.57% | |
$7.37B | 18.89 | 24.40% | 1.85% | ― | ― | ||
73 Outperform | C$576.54M | 14.42 | 12.45% | 0.94% | 11.03% | 18.83% | |
61 Neutral | C$122.26M | 30.45 | -19.69% | ― | 2.63% | -3376.73% | |
50 Neutral | C$23.77M | ― | -30.57% | ― | -8.08% | 46.56% | |
$4.81B | 38.32 | 21.90% | ― | ― | ― |